Literature DB >> 30390322

Diagnosing malignant pleural effusion using clinical and analytical parameters.

Yong Pan1, Wenjing Bai1, Jiangnan Chen2, Yijian Mao1, Xiaohong Qian1, Ke Xu1, Shaohua Tang1, Junwu Zhang3, Chong Chen1, Jingyi Chen1, Xingzhong Hu1.   

Abstract

BACKGROUND: Malignant pleural effusion (MPE) is common and diagnosis is often problematic. A cancer ratio (serum lactate dehydrogenases: pleural adenosine deaminase ratio) has been proposed for diagnosing MPE. However, the usefulness of this "cancer ratio" and the clinical-radiological criteria for diagnosing MPE has not been clearly determined to date. The aim of this study was to assess the performance of those parameters in the diagnosis of MPE.
METHODS: We analyzed 240 patients including 120 with MPE and 120 with non-MPE (93 tuberculous and 27 parapneumonic). Patients were divided into two groups: MPE and non-MPE (eg, tuberculous and parapneumonic). We constructed two predictive models to assess the probability of MPE: (a) clinical-radiological data only and (b) a combination of clinical-radiological data, the cancer ratio, and the carcinoembryonic antigen (CEA). The performances of the predictive models were assessed using receiver operating characteristic (ROC) curves and by examining the calibration.
RESULTS: The area under the ROC curves for model 1 and model 2 were excellent, 0.936 and 0.998, respectively. The overall diagnostic accuracies for model 1 and model 2 were 87.5% and 98.8%, respectively.
CONCLUSION: The results confirm that both models achieved a high diagnostic accuracy for MPE; however, model 2 was superior with the addition of its simplicity of use in daily practice. This model should be applied to determine which patients with a pleural effusion of unknown origin would not benefit from further invasive procedures.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  diagnosis; lactate dehydrogenases; logistic models; malignant; pleural effusion

Mesh:

Substances:

Year:  2018        PMID: 30390322      PMCID: PMC6818593          DOI: 10.1002/jcla.22689

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

1.  BTS guidelines for the investigation of a unilateral pleural effusion in adults.

Authors:  N A Maskell; R J A Butland
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES.

Authors:  R D GOLDMAN; N O KAPLAN; T C HALL
Journal:  Cancer Res       Date:  1964-04       Impact factor: 12.701

3.  Diagnosing malignant pleural effusion using clinical and analytical parameters.

Authors:  Yong Pan; Wenjing Bai; Jiangnan Chen; Yijian Mao; Xiaohong Qian; Ke Xu; Shaohua Tang; Junwu Zhang; Chong Chen; Jingyi Chen; Xingzhong Hu
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

Review 4.  Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion.

Authors:  F Rodriguez-Panadero; J P Janssen; P Astoul
Journal:  Eur Respir J       Date:  2006-08       Impact factor: 16.671

5.  Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.

Authors:  José Manuel Porcel; Manuel Vives; Aureli Esquerda; Antonieta Salud; Begoña Pérez; Francisco Rodríguez-Panadero
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

6.  Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.

Authors:  Jennifer S Hackbarth; Kazunori Murata; William M Reilly; Alicia Algeciras-Schimnich
Journal:  Clin Biochem       Date:  2010-06-08       Impact factor: 3.281

7.  Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.

Authors:  Jaume Ferrer; Juan Roldán; Joan Teixidor; Esther Pallisa; Ignasi Gich; Ferran Morell
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

8.  Medical thoracoscopy, results and complications in 146 patients: a retrospective study.

Authors:  M Hansen; P Faurschou; P Clementsen
Journal:  Respir Med       Date:  1998-02       Impact factor: 3.415

9.  Differentiating tuberculous from malignant pleural effusions: a scoring model.

Authors:  José Manuel Porcel; Manuel Vives
Journal:  Med Sci Monit       Date:  2003-05

10.  Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).

Authors:  Akash Verma; John Abisheganaden; R W Light
Journal:  Lung       Date:  2015-12-17       Impact factor: 2.584

View more
  6 in total

1.  Diagnosing malignant pleural effusion using clinical and analytical parameters.

Authors:  Yong Pan; Wenjing Bai; Jiangnan Chen; Yijian Mao; Xiaohong Qian; Ke Xu; Shaohua Tang; Junwu Zhang; Chong Chen; Jingyi Chen; Xingzhong Hu
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

2.  Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.

Authors:  Yan-Qiu Han; Lei Zhang; Li Yan; Pei-Heng Ouyang; Peng Li; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2019-10

3.  The clinical efficacy of external application of mirabilite and rhubarb combined with intrathoracic chemotherapy in treating malignant pleural effusion: A prospective, randomized, controlled clinical trial.

Authors:  Huachun Zhang; Mengyuan Jiang; Lirong Gao; Zhen Lin
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

4.  Echogenic swirling pattern, carcinoembryonic antigen, and lactate dehydrogenase in the diagnosis of malignant pleural effusion.

Authors:  Chih-Feng Chian; Fu-Ping Wu; Chen-Liang Tsai; Chung-Kan Peng; Chih-Hao Shen; Wann-Cherng Perng; Shih-Chang Hsu
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

5.  Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion.

Authors:  Mine Gayaf; Ceyda Anar; Mustafa Canbaz; Dursun Tatar; Filiz Güldaval
Journal:  Tanaffos       Date:  2021-03

6.  The clinical efficacy of traditional Chinese medicine in the treatment of malignant pleural effusion: A protocol of systematic review and meta-analysis.

Authors:  Zhen Lin; Mengyuan Jiang; Lirong Gao; Huachun Zhang
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.